Long Acting Naltrexone for Opioid Addiction: Focus on Sustained Abstinence and Recovery

NCT03647774 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

317

Enrollment

OTHER

Sponsor class

Conditions

Opioid-use Disorder

Interventions

DRUG: Extended release naltrexone

Sponsor

Lars Tanum

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]